This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n13http://linked.opendata.cz/resource/drugbank/drug/DB03533/identifier/pubchem-substance/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03533/identifier/drugbank/
n6http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB03533/identifier/chemspider/
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB03533/identifier/chebi/
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03533/identifier/pdb/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/resource/drugbank/drug/DB03533/identifier/pubchem-compound/

Statements

Subject Item
n2:DB03533
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03533 n11:DB03533
dcterms:title
Glycoluril
adms:identifier
n9:56138 n10:DB03533 n12:42946 n13:46508393 n14:GLL n15:62347
n3:synthesisReference
Ludwig Rottmaier, Rudolf Merten, "Glycoluril salts and a process for the preparation thereof." U.S. Patent US4433144, issued December, 1972.
n3:IUPAC-Name
n4:271B5135-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B513B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B513A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5137-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5138-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5139-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5133-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5134-363D-11E5-9242-09173F13E4C5 n4:271B5131-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5132-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5141-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5142-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B513C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B513D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B513F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B513E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5140-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5147-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5149-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B514A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5146-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5145-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5148-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5136-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5143-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5144-363D-11E5-9242-09173F13E4C5